Pharmacokinetics of Ambrisentan, a Novel Drug for Treatment of Pulmonary Arterial Hypertension (PAH), in Japanese Subjects
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-11-30
著者
-
Hirama Toshiyasu
Clinical Pharmacology Department Development & Medical Affairs Division Glaxosmithkline K. K.
-
NAKAHARA Norie
Clinical Pharmacology Department, Development & Medical Affairs Division, GlaxoSmithKline K. K.
-
WAKAMATSU Akira
Clinical Pharmacology Department, Development & Medical Affairs Division, GlaxoSmithKline K. K.
-
SHIMAMURA Ryutaro
Clinical Research Department 2, Development & Medical Affairs Division, GlaxoSmithKline K. K.
-
NOHDA Shigeru
Clinical Pharmacology Department, Development & Medical Affairs Division, GlaxoSmithKline K. K.
-
MIKI Shuji
Pre-Clinical Development Department, Development & Medical Affairs Division, GlaxoSmithKline K. K.
-
Miki Shuji
Pre-clinical Development Department Development & Medical Affairs Division Glaxosmithkline K. K.
-
Nakahara Norie
Clinical Pharmacology Department Development & Medical Affairs Division Glaxosmithkline K. K.
-
Wakamatsu Akira
Clinical Pharmacology Department Development & Medical Affairs Division Glaxosmithkline K. K.
-
Shimamura Ryutaro
Clinical Research Department 2 Development & Medical Affairs Division Glaxosmithkline K. K.
-
Nohda Shigeru
Clinical Pharmacology Department Development & Medical Affairs Division Glaxosmithkline K. K.
関連論文
- Pharmacokinetics of Ambrisentan, a Novel Drug for Treatment of Pulmonary Arterial Hypertension (PAH), in Japanese Subjects
- Pharmacokinetics of Adefovir after Oral Administration of Adefovir Dipivoxil 10mg in Healthy Japanese Males and Japanese Patients with Chronic Hepatitis B
- Pharmacokinetics and Pharmacodynamics of Eltrombopag in Healthy Japanese Males